Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
Open Access
- 23 March 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 493
Abstract
Selection of single antigen-specific B cells to identify their expressed antibodies is of considerable interest for evaluating human immune responses. Here, we present a method to identify single antibody-expressing cells using antigen-conjugated fluorescent beads. To establish this, we selected Folate Receptor alpha (FRα) as a model antigen and a mouse B cell line, expressing both the soluble and the membrane-bound forms of a human/mouse chimeric antibody (MOv18 IgG1) specific for FRα, as test antibody-expressing cells. Beads were conjugated to FRα using streptavidin/avidin-biotin bridges and used to select single cells expressing the membrane-bound form of anti-FRα. Bead-bound cells were single cell-sorted and processed for single cell RNA retrotranscription and PCR to isolate antibody heavy and light chain variable regions. Variable regions were then cloned and expressed as human IgG1/k antibodies. Like the original clone, engineered antibodies from single cells recognized native FRα. To evaluate whether antigen-coated beads could identify specific antibody-expressing cells in mixed immune cell populations, human peripheral blood mononuclear cells (PBMCs) were spiked with test antibody-expressing cells. Antigen-specific cells could comprise up to 75% of cells selected with antigen-conjugated beads when the frequency of the antigen-positive cells was 1:100 or higher. In PBMC pools, beads conjugated to recombinant antigens FRα and HER2 bound antigen-specific anti-FRα MOv18 and anti-HER2 Trastuzumab antibody-expressing cells, respectively. From melanoma patient-derived B cells selected with melanoma cell line-derived protein-coated fluorescent beads, we generated a monoclonal antibody that recognized melanoma antigen-coated beads. This approach may be further developed to facilitate analysis of B cells and their antibody profiles at the single cell level and to help unravel humoral immune repertoires.Keywords
Funding Information
- Breast Cancer Now (147)
- National Institute for Health Research (IS-BRC-1215-20006)
- Cancer Research UK (C30122/A11527, C30122/A15774, C10355/A15587)
- Medical Research Council (MR/L023091/1)
- Academy of Medical Sciences
This publication has 42 references indexed in Scilit:
- Novel Method for High-Throughput Full-Length IGHV-D-J Sequencing of the Immune Repertoire from Bulk B-Cells with Single-Cell ResolutionFrontiers in Immunology, 2017
- High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac DiseaseThe Journal of Immunology, 2017
- Human regulatory B cells in health and disease: therapeutic potentialJournal of Clinical Investigation, 2017
- Characterization of Antigen-Specific B Cells Using Nominal Antigen-Coated Flow-BeadsPLOS ONE, 2013
- Detection of expressed gene in isolated single cells in microchambers by a novel hot cell-direct RT-PCR methodThe Analyst, 2012
- Ex vivo characterization and isolation of rare memory B cells with antigen tetramersBlood, 2011
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004
- Antigen-Specific B Cell MemoryJournal of Experimental Medicine, 2000
- Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.1994